![](https://endpts.com/wp-content/uploads/2023/01/John-Rim-Samsung-Biologics-feature.jpg)
John Rim, Samsung Biologics CEO
Samsung Biologics moves up plans to open its $1.5B+ plant
Samsung Biologics, the contract manufacturing arm of the South Korean-based conglomerate Samsung, plans to open the doors to one of its factories a little sooner …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.